defects), eyes (anophtalmos, microphthalmia, cataract, choroid or retinal coloboma), and face (facial asymmetry, hypoplastic alae nasi, abnormal ear morphology, and dental defects). 2 The molecular basis of GS was first described in 2007, when it was reported that GS is caused by loss-of-function mutations in the PORCN gene. 3, 4 PORCN is the human homolog of a Drosophila polarity gene "porcupine", located on the X chromosome (Xp11.23). The PORCN gene encodes a 461-amino acid 52-kDa endoplasmic reticulum protein, the porcupine protein, thought to be important for modification and excretion of Wnt proteins. 5, 6 Wnt proteins are critical for interactions between ectoderm and mesoderm during embryogenesis. 4, 7 From what is known today, PORCN is the only gene associated with GS. A total of 171 different mutations are registered in the online PORCN mutation database (http://www. lovd.nl/PORCN. Accessed on February 6, 2018) , and these are scattered throughout the entire coding sequence of the PORCN gene. 8 The phenotype in GS male patients is not extensively depictured, and it has not been reported how many male patients exist in total with a confirmed molecular diagnosis. This report aims to further clarify the genotype-phenotype correlation of GS in males, which is important since male patients might have been missed or misinterpreted.
| MATERIALS AND METHODS

| Study approval
The study was performed in accordance with the Declaration of Helsinki, and the local ethical board in Stockholm approved the study. Informed consent was obtained from the family according to local ethical guidelines, and the publication of clinical data and pictures has been approved by the parents.
| Genetic analysis
Genomic DNA was extracted from blood lymphocytes and fibroblasts from skin biopsies from affected and normal skin by standard protocols. The PORCN gene was amplified by PCR and screened for mutations by genomic sequencing of both DNA strands of the entire coding region and the highly conserved exon-intron splice junctions. We performed digital PCR (QuantStudio 3D; Applied Biosystems, Foster City, CA, USA) using the manufacturer's protocol. For array comparative genomic hybridization (CGH), a custom 4x180K array CGH platform was used (Oxford Gene Technologies, Oxfordshire, UK). This platform has a genomewide average base pair spacing of about 20 Kb. Experiments were performed according to the manufacturer's protocol.
| RESULTS
| Clinical report
A 3-year-old male was referred to the Department of Dermatology at Danderyd Hospital in Stockholm to explore multiple skin aberrations. The patient had been adopted from China, and his medical history was unknown. The patient had several abnormalities: His face was asymmetric with a right-sided hypoplasia, widely spaced teeth, and low set ears ( Figure 1A ). There was hypopigmentation in a blaschkolinear distribution on his right arm ( Figure 1B) . Telangiectasia was present on both arms ( Figure 1B ) and on the left leg ( Figure 1D ) in a blaschkolinear distribution. He had atrophic skin with nodular fat herniation clustered on the right-side trunk ( Figure 1C ). There were areas of patchy skin aplasia on his right leg ( Figure 1D ). His right foot showed partial ectrodactyly of the second toe ( Figure 1D ). He had clinodactyly on both hands and a complete syndactyly of the third and fourth fingers of the left hand ( Figure 1E ). All the nails of the left hand and the nails of the second and third finger of the right hand were ridged. In addition, he had a right-sided dacryostenosis, short stature (−4 SD), inguinal hernia, and osteopathia striata. A diagnosis of GS was suspected clinically.
| Histopathological findings
Skin biopsies were performed on the atrophic patches, and microscopy showed thinning of dermis, few collagen structures, and herniation of fat lobules in the upper dermis ( Figure 1E ).
| Genetic findings
A previously unreported mosaic variant in exon 14, c.1274_1275del (p.Thr425Argfs*45) (NM_203475.2), was identified in samples of blood, affected skin, and normal skin by Sanger sequencing. To quantify the mosaic levels in each tissue, we performed digital PCR which showed the variant in 72% of the cells in affected skin, 49% in normal skin, and 47% in blood. The variant creates a frame shift starting at codon Thr425. The new reading frame ends in a stop codon 44 positions downstream. This PORCN variant was classified as likely pathogenic. Array CGH was normal and excluded Klinefelter syndrome.
| DISCUSSION
This paper describes a mosaic GS male patient with a previously unreported PORCN variant and gives an overview of genetic and clinical findings in all male patients. To the best of our knowledge, this is the 24th GS male patient reported with a confirmed molecular diagnosis.
The clinical presentation of our patient is typical for GS and in accordance with the proposed diagnosis criteria. 2 In addition, the detected variant leads to a stop codon, which makes the diagnosis GS very likely. However, mosaic levels were also found in unaffected tissue. We conclude that the mutation exists in both affected and unaffected tissue, but in a higher percentage in affected tissue. It has been observed in other mosaic disorders that the mutation percentage may vary and that mutations can occur even in seemingly unaffected tissue. 9, 10 When reviewing the literature, we found more than 400 reported GS patients. 11, 12 GS was long presumed to be lethal in males. 13, 14 However, later reports have shown that approximately 10% of all GS patients are males. 2, 15 The majority of surviving males can be explained by mosaicism for PORCN mutations that arise postzygotically during embryogenesis 16 or Klinefelter syndrome, since these males carry an additional X chromosome. 5 There is no genotype-phenotype correlation, which can be explained by random X-inactivation in females or mosaicism. [17] [18] [19] Of the 24 reported male patients, 19 are mosaics, one patient has Klinefelter syndrome, and four patients from two different families are non-mosaics (Table 1) . Interestingly, all four patients with non-mosaic PORCN mutations lacked skin manifestations but had other severe symptoms compatible with GS. 20, 21 In addition, diaphragm abnormalities were detected in two patients, resembling previously reported cases with pentalogy of Cantrell. 18, 22 When reviewing the literature of GS male patients with a confirmed molecular diagnosis, we noticed that skin findings, syndactyly, ocular defects, and ectrodactyly are common clinical features (Table 1) . A study from 2016, including 18 patients with GS, demonstrated a higher incidence of ophthalmologic manifestations in patients with GS than previously reported (77% vs 40%). 23 In our review over reported male patients, we found that 15 out of 24 (62.5%) had ocular manifestations (Table 1) . However, ocular defects are not part of previously suggested clinical diagnosis criteria. 2 Our suggestion is that GS should be suspected even in the absence of skin findings, if other typical signs occur, such as characteristic limb malformations or ocular defects, including coloboma or microphthalmia. Ocular manifestation should be considered as a major sign of GS, which has been suggested earlier. 24 In summary, GS is a rare multisystem disorder with highly variable expressivity. This report serves to further clarify the phenotype of GS in males, which is important since there are, to our knowledge, only 24 male patients described with a confirmed molecular diagnosis. The highly variable expressivity might have caused male patients to be missed or misinterpreted until today. Our report adds to the knowledge of genotype-phenotype correlations in male patients with PORCN mutations and highlights that PORCN mutations can be suspected in patients with characteristic limb malformations, such as ectrodactyly, or ocular manifestations, even in the absence of characteristic skin findings. 
